The Standard

By Brian Douthit; Charles Jaffe, MD, PhD; Viet Nguyen, MD; and Titus Schleyer, DMD, PhD

Originally starting as an application showcase in 2018, the FHIR Apps Competition has become one of the most popular sessions at the AMIA Annual Symposium. From clinical decision support and health information exchange to problem-oriented displays and back-end data exchange, HL7 FHIR is enabling innovation across a whole range of health IT domains.

AMIA and HL7 recently reinvigorated their partnership to emphasize the importance of health data standards in informatics, and engage the AMIA implementer community in leveraging FHIR for research, patient care and education. The competition is intended to highlight the best and most innovative FHIR implementations – if you are planning to attend the Annual Symposium this year, you don’t want to miss it!

Opportunity to Advance Your Career with an HL7 Informatics Internship

• Remote-based/online internship
• $5,000 USD monthly stipend
• 12-16 weeks
• Must be eligible to work in the United States

We want to hire and mentor a motivated informatics trainee who wants to learn, contribute, and advance the industry’s approach to solving the thorny problems of health data interoperability. This internship will focus specifically on synthesizing best practices for using standard terminologies within HL7’s specifications. You will be working with world-class experts, learning how consensus-driven standards are transforming data exchange, and building a key resource for the global health standards community.

Two CodeX HL7 FHIR Accelerator use case teams are hosting monthly public calls to involve a broad community in early prototype development and pilot planning activities currently underway.

Computable Publishing LLC was pleased to sponsor the January 2022 HL7 Working Group Meeting, which aligns with our work towards creating software tools that support data exchange for scientific knowledge with HL7 Fast Healthcare Interoperability Resources (FHIR®). In fact, many already know that our CEO, Brian Alper, is the leader of the Evidence-Based Medicine on the FHIR project (EBMonFHIR) and the COVID-19 Knowledge Accelerator (COKA) initiative.

Background & Expansion

EBMonFHIR (sponsored by the CDS, BR&R and CQI HL7 work groups) previously created Citation, Evidence, EvidenceReport and Evidenceariable Resources. The project expansion to the COKA initiative now involves 12 active working group meetings per week. The combination of volunteer efforts from about 100 people in many countries along with software tools (provided gratis to COKA by Computable Publishing LLC) has produced impressive results to advance evidence-based medicine (EBM) and promote the HL7 FHIR standard to the EBM community.

To our HL7 International community,

The past two years have been challenging for all of us, and now the world is faced with the unfolding conflict in Eastern Europe.

We are sure that the events of the past 24 hours have left you, as they have us, saddened.

HL7 has a long-standing history of global participation, support and collaboration from across the world. We are proud to have such a united community dedicated to the advancement of interoperability and the betterment of healthcare across the world. Our mutual goals and passion have brought together individuals from diverse communities who have created strong bonds and friendships through their work within HL7.

On behalf of the HL7 US Realm Steering Committee (USRSC), we are pleased to share an update on last year's priorities and highlight our focus for 2022.

2021 Highlights

Visibility was a key theme of our work in 2021 and included supporting pilot work on a standards dashboard, tracking accelerator activity and promoting key ballots.

Before we dive into 2022, we want to highlight a few key points for all US Realm (USR) members.

• SMART v2: published new guidance on granular controls
• Bulk Data v2: published with numerous new features 
• Errata release of Consolidated CDA (C-CDA): companion guide to support January 2022 ballot  
• C-CDA Companion Guide: January 2022 ballot to add USCDI v2 guidance
• US FHIR Core - January 2022 ballot: to add USCDI v2 guidance
• Hosted reviews on HL7 Standards Dashboard Prototype
• C-CDA Web Publishing Trial Draft using FHIR Structure Definition
• Facilitated US@ project with ONC team

The CodeX HL7 FHIR Accelerator will host three public calls next week covering project milestones in the Radiation Therapy Treatment Data (RTTD), Risk Evaluation and Mitigation Strategies[i] (REMS) and Prior Authorization in Oncology use cases.

• Join the CodeX Prior Authorization in Oncology team on February 15 (3-4 ET) for an update on its radiation oncology pilot planning. Use case team members will discuss progress relative to breast and prostate cancer patient demographic and clinical data elements discovery and health data standards mapping (e.g., mCODE and Da Vinci Project implementation guides). Find call information here.  
• Join the RTTD team on February 16 (11-12 ET) when they will share recent project achievements, including experience exchanging synthetic patient data using mCODE from a radiation oncology information test system to a FHIR server. Find call information here.
• Join the CodeX REMS team on February 17 (1-2 ET) to explore the value of an interoperable REMS ecosystem using FHIR and other health data standards, view details of the open source REMS on FHIR prototype under development and discuss CodeX membership details and benefits, including driving the REMS use case work forward. Find call information here.

The CodeX team believes the Minimal Common Oncology Data Elements (mCODE™) standard could be leveraged to achieve more equitable health outcomes for cancer patients from diverse populations. As part of our exploration, we are releasing a white paper, “Advancing Health Equity in Cancer Research, Care, and Surveillance,” available here and will host a companion webinar, "Leveraging Interoperability to Drive Health Equity in Cancer Care, Research and Surveillance." Please join us on January 27, 2022 at 1PM ET by registering here.